Search
 
Home Page
 
 
About Our Center
 
 
Making an Appointment
 
 
Contact Us
 
 
Meet Our Team
 
 
Patient to Patient
 
 
Ovarian Cancer Basics
 
 
Genetic Testing and Risk Assessment
 
 
Treatment at Johns Hopkins
 
 
Clinical Trials
 
 
Research at Johns Hopkins
 
 
Support Services
 
 
Physician to Physician
 
  • NCCN Practice Guidelines
     
  • Conferences, CME Courses, Scientific Symposiums
     
  • Fellowship/Training Programs
     
  • Journal Club
     
  • Case Studies
     
     
    Make a Contribution
     
     
    About This Site
     
     
    Kimmel Cancer Center Home
     
    The Johns Hopkins Ovarian Cancer Center of Excellence acknowledges and thanks Aventis, Genzyme, GlaxoSmithKline, Oncotech, Ortho Biotech, and The Pam McDonald Fund for their support of this website through provision of unrestricted educational grants.
    NCICCC Logo
    The Johns Hopkins Ovarian Cancer Center of Excellence

    Journal Club - September 2004

    Influence of hospital procedure volume on ovarian cancer survival in Japan, a country with low incidence of ovarian cancer.
    Ioka A, Tsukuma H, Ajiki W, Oshima A.
    Cancer Sci 2004; 95: 233-237. [Abstract]
    http://cancer-sci.bcasj.or.jp/

    Summary
    This was a population-based study that was carried out to evaluate the potential association between survival of ovarian cancer patients and the volume of ovarian cancer surgery performed at hospitals in Japan. Overall, 2450 cases of ovarian cancer were identified between the study years of 1975 to 1995. Hospitals (n=208) were divided according the average annual number of ovarian cancer surgeries: high-volume (8.8 operations per year), medium-volume (4.0 operations per year), low-volume (2.0 operations per year), and very low-volume (0.3 operations per year). For all ovarian cancer patients, the 5-year relative overall survival rate was 38.8%.  Statistical analysis revealed that 5-year survival time was significantly correlated with hospital ovarian cancer surgical volume:  very low-volume hospital = 22.3%, low-volume hospital = 34.2%, medium-volume hospital = 46.2%, and high-volume hospital = 55.0%. After adjusting for potential confounding effects of other clinical variables, patients who received surgery for ovarian cancer at a very low-volume hospital had a 60% higher risk of death from ovarian cancer than patients operated on at high-volume hospitals.

    Discussion
    Important limitations of this study are a product of the blunt instrument population-based database used for the analyses. Specifically, the analysis did not include information on other medical problems, aside from ovarian cancer, that might have influenced survival, and staging information was unable to be verified. Strengths of the study include the large size of the population examined and the precision in categorizing the number of surgeries performed at each hospital.

    Conclusion
    These results provide further objective evidence that centralization of care for patients undergoing surgery for ovarian cancer in a high-volume center results in improved survival rates.  More information: Recent data from Johns Hopkins on ovarian cancer surgery rates in Maryland.

    Back to Journal Club Archives

    Contact Us Site Map Maps & Directions Return to Hopkins Kimmel Cancer Center Home Page Please Read Our Legal and Disclaimer Notice Contact the Webmaster